Kwality Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 539997 Small Cap ISIN: INE552U01010

As on 18 November 2025 at 23:47 IST

₹948.05

-2.30

(-0.24%)

Sell Buy

Over 1 Month

9.50%

Over 6 Months

15.09%

Over 1 Year

4.75%

Over 3 Years

173.96%

Kwality Pharmaceuticals Ltd Summary

Close ₹950.35

Open ₹978.60

High ₹978.60

Low ₹942.10

Volume 13,483

Net Turnover (in Cr) ₹1.29

52Wk High ₹1,235

52Wk Low ₹596.05

52Wk High / Low

596.05

1,235

Kwality Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹986.10

EPS (TTM) 47.31

Book Value (BV) 280.56

Div. Yield -

P/E (TTM) 20.09

Price/Book Value 3.39

Delivery % 50.86 %

Face Value 10

Key Ratios

PE Ratio 22.61

PB Ratio 3.40

EV to Sales 2.70

PEG Ratio 0.34

ROA 10.54

ROE 16.27

Debt-Equity 0.43

Net Profit Margin 10.78

Operating Profit Margin 22.25

Kwality Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	372.12	309	253.97	459.70	263.60
Total Expenses	317.98	270.80	211.87	298.13	242.33
Profit Before Tax	54.14	31.10	25.57	161.57	21.27
Profit After Tax	39.80	23.62	19.28	119.94	14.89
Operating Profit After Depreciation	64.02	48.58	48.12	164.48	23.94

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	145.69	139.05	120.50	91.73	56.53
Total Non Current Assets	163.49	151.52	146.43	112.77	60.36
Total Current Assets	283.78	242.69	207.20	227.82	105.90
Total Assets	447.27	394.21	353.63	340.59	166.26
Total Shareholder's Fund	264.05	224.21	200.52	181.14	61.15

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	52.72	42.98	41.38	60.60	26.71
Net Cash Used In Investing Activities	-28.52	-26.40	-48.44	-62.93	-23.20
Net Cash Used In Financing Activities	-14.44	-17.40	0.99	5.66	0.77

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	372.12	309	253.94	459.64	263.09
Total Expenses	317.89	270.44	211.65	297.97	241.29
Profit Before Tax	54.23	31.47	25.76	161.67	21.80
Profit After Tax	39.89	23.98	19.47	120.05	15.41
Operating Profit After Depreciation	64.10	48.95	48.31	164.59	24.41

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	144.47	138.18	119.57	90.77	55.52
Total Non Current Assets	165.82	154.19	149.06	115.36	62.90
Total Current Assets	284.90	243.38	207.52	227.32	105.88
Total Assets	450.72	397.57	356.58	342.68	168.78
Total Shareholder's Fund	265.84	225.94	202.03	182.56	62.51

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	52.77	43.35	42.19	59.24	26.36
Net Cash Used In Investing Activities	-28.13	-26.40	-48.44	-62.98	-23.20
Net Cash Used In Financing Activities	-14.44	-17.40	0.99	5.66	0.83

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	111.05	111.48	115.68	84.41	90.03
Total Expenses	85.70	87.31	89.78	66.91	70.38
Profit Before Tax	18.45	17.03	19.09	11.39	12.54
Profit After Tax	14.12	11.92	14.48	8.52	8.46
Operating Profit after Depreciation	26.25	24.55	26.67	18.15	19.87

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	111.31	111.48	115.68	84.41	90.03
Total Expenses	85.96	87.29	89.78	66.90	70.36
Profit Before Tax	18.45	17.05	19.10	11.41	12.57
Profit After Tax	14.12	11.93	14.50	8.54	8.49
Operating Profit after Depreciation	26.25	24.57	26.67	18.16	19.89

Kwality Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 935.43

S2 920.52

S3 898.93

Pivot 957.02

R1 971.93

R2 993.52

R3 1,008.43

Moving Average

20 SMA 896.80

50 SMA 915.28

100 SMA 1,007.07

200 SMA 908.45

Kwality Pharmaceuticals Ltd Corporate Actions

No available data

AGM Date: 30 Nov 2020

AGM 30/11/2020 This is to inform you under regulation 30 and any other regulations of SEBI (LODR) Regulations, 2015 that meeting of the Board of Directors of the company was held on 5th November, 2020 and the said meeting commenced at 5:00 P.M. and concluded at 07:15 P.M. at the registered office of the Company. The following matters were decided by the board: 1. The Board of directors of the company have considered and approved the Report of Board of Directors under Section 134 of the Companies Act, 2013. 2. The Board of directors of the company have considered and approved the Notice of 37th Annual General Meeting of the Company. 3. Date, Time and Place of the 37th Annual General Meeting has been fixed. 4. Dates of Book Closure for the purpose of 37th Annual General Meeting has been fixed and approved by the Board. In terms of regulation 30 read with Part A of Schedule III of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015, enclosed are the proceedings of the 37th Annual General Meeting (AGM) of the Company held on Monday, 30th November, 2020 at 11:30 A.M. at the registered Office of the Company situated at 'VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR - 143601'. (As per BSE Announcement Dated on 30/11/2020)

AGM Date: 30 Sep 2021

AGM 30/09/2021 Please find attached herewith copy of notice of 38TH AGM to be held on Thursday 30th September, 2021 at the Regd Office of the company situated at VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR, PUNJAB-143601. In terms of regulation 30 read with Part A of Schedule III of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015, enclosed are the proceedings of the 38th Annual General Meeting (AGM) of the Company held on Thursday, 30th September, 2021 at 11:30 A.M. at the registered Office of the Company situated at 'VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR - 143601'. (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

AGM 30/09/2022 The following matters were decided by the board: 1. The Board of directors of the company have considered and approved the Report of Board of Directors under Section 134 of the Companies Act, 2013 for the year ended 31st March, 2022. 2.The Board of directors of the company have considered and approved the Notice of 39th Annual General Meeting of the Company. 3. Date, Time and Place of the 39thAnnual General Meeting has been fixed. 4. Dates of Book Closure for the purpose of 39th Annual General Meeting has been fixed and approved by the Board. 5. Considered and approved E-voting facility: E-voting facility for the Shareholders shall commence from 27th September, 2022 at 9:00 A.M. to 29th September, 2022, 5:00 P.M. 6. Considered and approved Mr. Rishi Mittal, Practicing Company Secretary as Scrutinizer for 39th Annual General Meeting to held on 30th September, 2022. (As Per BSE Announcement Dated on 06.09.2022) In terms of regulation 30 read with Part A of Schedule III of SEBI (Listing obligations & Disclosure Requirements) Regulations, 2015, enclosed are the proceedings of the 39th Annual General Meeting (AGM) of the Company held on Friday, 30th September, 2022 at 11:30 A.M. at the registered Office of the Company situated at 'VILLAGE NAGKALAN, MAJITHA ROAD, AMRITSAR - 143601'. (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 Outcome of Board meeting held on September 06, 2023 (As Per BSE Announcement Dated on 06.09.2023) Disclosure of E Voting Results and Scrutinizer''s Report of 40th AGM (As per BSE Announcement Dated on 04/10/2023)

AGM Date: 24 Sep 2024

AGM 24/09/2024 NOTICE OF AGM ENCLOSED (As Per BSE Announcement Dated on: 31/08/2024) Proceedings of AGM (As Per BSE Announcement Dated on: 24/09/2024) Scrutinizer Report (As Per BSE Announcement Dated on: 26/09/2024)

AGM Date: 09 Sep 2025

AGM 09/09/2025 This is to inform you under Regulation 30 and any other regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the Board of Directors of the Company at its meeting held today i.e. Saturday, August 16, 2025 inter-alia has taken the following decisions:- 1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31, 2025 under section 134 of the Companies Act, 2013. 2. The Board of Directors of the Company have considered and approved the Notice of 42nd Annual General Meeting of the Company. 3. The Board has approved the day, date, time and calendar of events and Notice of 42nd Annual General Meeting of the company to be held on Tuesday 09th September, 2025 at 12:00 noon, through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). * OTHER DETAILS AS PER ATTACHMENT Read less.. (As Per BSE Announcement Dated on 16.08.2025) Proceedings of 42nd AGM are enclosed herewith (As Per Bse Announcement dated on 09/09/2025)

Kwality Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Kwality Pharmaceuticals Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.03%

Kwality Pharmaceuticals Ltd News

Kwality Pharmaceuticals to table results

On 13 November 2025

06 Nov 2025, 12:48 pm

Kwality Pharmaceuticals to conduct AGM

On 9 September 2025

19 Aug 2025, 10:40 am

Kwality Pharma secures regulatory approval for anti-cancer drug Bleomycin in Mexico

Kwality Pharmaceuticals announced that it has received registration for Bleomycin 15 IU in Mexico for sale and distribution.

18 Aug 2025, 02:05 pm

KPL receives nod to sell its anti-cancer drug Bleomycin 15 IU in Mexico

18 Aug 2025, 12:05 pm

Kwality Pharmaceuticals schedules board meeting

On 11 August 2025

05 Aug 2025, 06:12 pm

Kwality Pharmaceuticals Ltd Stock Analysis

Annual revenue for Kwality Pharmaceuticals Ltd increased by 20.43% to ₹372.12 crore in FY 2025 from ₹309 crore in FY 2024.
Annual Net Profit for Kwality Pharmaceuticals Ltd increased by 66.32% to ₹39.89 crore in FY 2025 from ₹23.98 crore in FY 2024.
Promoter Shareholding in Kwality Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 54.83% in June 2025 to 54.83% in September 2025.
Kwality Pharmaceuticals Ltd delivered a 1-year return of 4.75% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Kwality Pharmaceuticals Ltd share price moved down by 0.24% from its previous close of INR ₹950.35. The latest Kwality Pharmaceuticals Ltd share price is INR ₹948.05.
Kwality Pharmaceuticals Ltd share price today has been at a low of 938.25 and a high of 967.80. Over the past 52 weeks, the Kwality Pharmaceuticals Ltd share price has seen a low of 596.05 and a high of 1,235.